FDA Issues Recall for Blood Pressure Drug Over Efficacy Concerns

The U.S. Food and Drug Administration has initiated a Class II recall for over 11,000 bottles of chlorthalidone tablets, a medication used to treat high blood pressure. This action stems from the tablets failing dissolution specifications, which could prevent the drug from breaking down properly in the body. Consequently, affected patients may not receive the intended dose, potentially rendering the medication less effective. The recall targets specific batch codes and expiration dates of the 25 mg tablets.